Bao Pharma
Latest round
- Series C
Last raised
- Jul 2024
Total raised
- $100M
Investors
- 11
About Bao Pharma
, trading as Bao Pharma, is a biopharmaceutical company that engages in R&D, and production of recombinant protein drugs and antibody drugs. The company has two R&D centres in Suzhou and Chengdu. The founder, Yanjun Liu, graduated from the Naval Medicine Department of Shanghai Second Military Medical University. Bao Pharma has applied for 51 invention patents.38 apiece on the Hong Kong Exchanges and Clearing (HKEX) under the ticker "2659". Bao Pharma focuses on the R&D of recombinant human hyaluronate subcutaneous drug delivery technology and assisted reproduction drugs. It established a medical enzyme engineering technology platform, a glycoprotein drug engineering technology platform, and an antibody target enzyme engineering technology platform. Specific drugs include lyophilized powder for injection and pre-filled disposable injection. The company's product pipeline includes recombinant human hyaluronate, recombinant human follicle-stimulating hormone-CTP fusion protein and recombinant immunoglobulin degrading enzyme. The company generates revenue by developing synthetic biology biopharmaceuticals.
Who invested in Bao Pharma
11 investors across 3 rounds
See all investors in Bao Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bao Pharma
Who invested in Bao Pharma?
Bao Pharma has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bao Pharma raised?
Bao Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bao Pharma last raise money?
Bao Pharma's most recent round on record is a Series C, in Jul 2024.
What does Bao Pharma do?
, trading as Bao Pharma, is a biopharmaceutical company that engages in R&D, and production of recombinant protein drugs and antibody drugs.
Where is Bao Pharma headquartered?
Bao Pharma is headquartered in Shanghai, China.
Which VCs invest in companies like Bao Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Bao Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Bao Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.